Asia-Pacific Metabolic Disorders Market Outlook to 2036 - Diabetes Assays and Cholesterol Tests

1.1 What Is This Report About?
1.2 Metabolic Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report

2.1 Metabolic Disorders Market, Asia-Pacific, Revenue ($m), 2024-2036
2.2 Metabolic Disorders Market, Asia-Pacific, Revenue ($m), 2024-2036
2.3 Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
2.4 Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
2.5 Metabolic Disorders Market, Asia-Pacific, Company Share by Revenue ($m), 2025

3.1 Metabolic Disorders Market, Australia, Revenue ($m), 2024-2036
3.1.1 Cholesterol Tests Market, Australia, Revenue ($m), by Segment, 2024-2036
3.1.2 Diabetes Assays Market, Australia, Revenue ($m), by Segment, 2024-2036
3.2 Metabolic Disorders Market, Australia, Volume (Units), 2024-2036
3.2.1 Cholesterol Tests Market, Australia, Volume (Units), by Segment, 2024-2036
3.2.2 Diabetes Assays Market, Australia, Volume (Units), by Segment, 2024-2036
3.3 Metabolic Disorders Market, Australia, Average Price ($), 2024-2036
3.4 Metabolic Disorders Market, Australia, Company Share by Revenue ($m), 2025

4.1 Metabolic Disorders Market, China, Revenue ($m), 2024-2036
4.1.1 Cholesterol Tests Market, China, Revenue ($m), by Segment, 2024-2036
4.1.2 Diabetes Assays Market, China, Revenue ($m), by Segment, 2024-2036
4.2 Metabolic Disorders Market, China, Volume (Units), 2024-2036
4.2.1 Cholesterol Tests Market, China, Volume (Units), by Segment, 2024-2036
4.2.2 Diabetes Assays Market, China, Volume (Units), by Segment, 2024-2036
4.3 Metabolic Disorders Market, China, Average Price ($), 2024-2036
4.4 Metabolic Disorders Market, China, Company Share by Revenue ($m), 2025

5.1 Metabolic Disorders Market, India, Revenue ($m), 2024-2036
5.1.1 Cholesterol Tests Market, India, Revenue ($m), by Segment, 2024-2036
5.1.2 Diabetes Assays Market, India, Revenue ($m), by Segment, 2024-2036
5.2 Metabolic Disorders Market, India, Volume (Units), 2024-2036
5.2.1 Cholesterol Tests Market, India, Volume (Units), by Segment, 2024-2036
5.2.2 Diabetes Assays Market, India, Volume (Units), by Segment, 2024-2036
5.3 Metabolic Disorders Market, India, Average Price ($), 2024-2036
5.4 Metabolic Disorders Market, India, Company Share by Revenue ($m), 2025

6.1 Metabolic Disorders Market, Japan, Revenue ($m), 2024-2036
6.1.1 Cholesterol Tests Market, Japan, Revenue ($m), by Segment, 2024-2036
6.1.2 Diabetes Assays Market, Japan, Revenue ($m), by Segment, 2024-2036
6.2 Metabolic Disorders Market, Japan, Volume (Units), 2024-2036
6.2.1 Cholesterol Tests Market, Japan, Volume (Units), by Segment, 2024-2036
6.2.2 Diabetes Assays Market, Japan, Volume (Units), by Segment, 2024-2036
6.3 Metabolic Disorders Market, Japan, Average Price ($), 2024-2036
6.4 Metabolic Disorders Market, Japan, Company Share by Revenue ($m), 2025

7.1 Metabolic Disorders Market, South Korea, Revenue ($m), 2024-2036
7.1.1 Cholesterol Tests Market, South Korea, Revenue ($m), by Segment, 2024-2036
7.1.2 Diabetes Assays Market, South Korea, Revenue ($m), by Segment, 2024-2036
7.2 Metabolic Disorders Market, South Korea, Volume (Units), 2024-2036
7.2.1 Cholesterol Tests Market, South Korea, Volume (Units), by Segment, 2024-2036
7.2.2 Diabetes Assays Market, South Korea, Volume (Units), by Segment, 2024-2036
7.3 Metabolic Disorders Market, South Korea, Average Price ($), 2024-2036
7.4 Metabolic Disorders Market, South Korea, Company Share by Revenue ($m), 2025

8.1 Metabolic Disorders Market Pipeline Products
8.2 Metabolic Disorders - Pipeline Products by Stage of Development
8.3 Metabolic Disorders - Pipeline Products by Segment
8.4 Metabolic Disorders - Pipeline Products by Territory
8.5 Metabolic Disorders - Pipeline Products by Regulatory Path
8.6 Metabolic Disorders - Pipeline Products by Estimated Approval Date

9.1 Roche Diagnostics International Ltd
9.1.1 Company Overview
9.2 Siemens Healthineers AG
9.2.1 Company Overview
9.3 Abbott Laboratories
9.3.1 Company Overview
9.4 Beckman Coulter Inc
9.4.1 Company Overview

10.1 Corporate Communications
10.1.1 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors
10.1.2 Nov 06, 2025: TEDCO Signs Agreement for Up to $50 Million Investment with TAIIDA and SFIC Group
10.2 Other Significant Developments
10.2.1 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors
10.2.2 Oct 22, 2025: Visionary Holdings Launches Joint Venture in Toronto for Stem Cell Therapy Commercialization
10.3 Product News
10.3.1 Mar 11, 2026: PatentVest Announces Intellectual Property Collaboration With Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics
10.3.2 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
10.3.3 Nov 17, 2025: ScreenCell Standardizes CTC Isolation Kits to Two Filtration Units
10.3.4 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.3.5 Sep 29, 2025: Fish Oil Supplements May Not Ensure Heart Protection
10.3.6 Sep 19, 2025: Boditech Med Launches Advanced Diabetes Diagnostics at EASD 2025
10.4 Strategy And Business Planning
10.4.1 Mar 11, 2026: PatentVest Announces Intellectual Property Collaboration With Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics
10.4.2 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.4.3 Nov 06, 2025: TEDCO Signs Agreement for Up to $50 Million Investment with TAIIDA and SFIC Group
10.4.4 Oct 22, 2025: Visionary Holdings Launches Joint Venture in Toronto for Stem Cell Therapy Commercialization

11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 the Analyst Consulting
11.3 Contact Us
11.4 Disclaimer

Table 1: Metabolic Disorders Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Table 2: Metabolic Disorders Market, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Table 3: Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
Table 4: Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
Table 5: Metabolic Disorders Market, Asia-Pacific, Company Share by Revenue ($m), 2025
Table 6: Metabolic Disorders Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 7: Cholesterol Tests Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 8: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 9: Metabolic Disorders Market, Australia, Volume (Units), 2024-2036
Table 10: Cholesterol Tests Market, Australia, Volume (Units), 2024-2036
Table 11: Diabetes Assays Market, Australia, Volume (Units), 2024-2036
Table 12: Metabolic Disorders Market, Australia, Average Price ($), 2024-2036
Table 13: Metabolic Disorders Market, Australia, Company Share by Revenue ($m), USD Constant, 2025
Table 14: Metabolic Disorders Market, China, Revenue ($m), USD Constant, 2024-2036
Table 15: Cholesterol Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Table 16: Diabetes Assays Market, China, Revenue ($m), USD Constant, 2024-2036
Table 17: Metabolic Disorders Market, China, Volume (Units), 2024-2036
Table 18: Cholesterol Tests Market, China, Volume (Units), 2024-2036
Table 19: Diabetes Assays Market, China, Volume (Units), 2024-2036
Table 20: Metabolic Disorders Market, China, Average Price ($), 2024-2036
Table 21: Metabolic Disorders Market, China, Company Share by Revenue ($m), USD Constant, 2025
Table 22: Metabolic Disorders Market, India, Revenue ($m), USD Constant, 2024-2036
Table 23: Cholesterol Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Table 24: Diabetes Assays Market, India, Revenue ($m), USD Constant, 2024-2036
Table 25: Metabolic Disorders Market, India, Volume (Units), 2024-2036
Table 26: Cholesterol Tests Market, India, Volume (Units), 2024-2036
Table 27: Diabetes Assays Market, India, Volume (Units), 2024-2036
Table 28: Metabolic Disorders Market, India, Average Price ($), 2024-2036
Table 29: Metabolic Disorders Market, India, Company Share by Revenue ($m), USD Constant, 2025
Table 30: Metabolic Disorders Market, Japan, Revenue ($m), USD Constant, 2024-2036
Table 31: Cholesterol Tests Market, Japan, Revenue ($m), USD Constant, 2024-2036
Table 32: Diabetes Assays Market, Japan, Revenue ($m), USD Constant, 2024-2036
Table 33: Metabolic Disorders Market, Japan, Volume (Units), 2024-2036
Table 34: Cholesterol Tests Market, Japan, Volume (Units), 2024-2036
Table 35: Diabetes Assays Market, Japan, Volume (Units), 2024-2036
Table 36: Metabolic Disorders Market, Japan, Average Price ($), 2024-2036
Table 37: Metabolic Disorders Market, Japan, Company Share by Revenue ($m), USD Constant, 2025
Table 38: Metabolic Disorders Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 39: Cholesterol Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 40: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 41: Metabolic Disorders Market, South Korea, Volume (Units), 2024-2036
Table 42: Cholesterol Tests Market, South Korea, Volume (Units), 2024-2036
Table 43: Diabetes Assays Market, South Korea, Volume (Units), 2024-2036
Table 44: Metabolic Disorders Market, South Korea, Average Price ($), 2024-2036
Table 45: Metabolic Disorders Market, South Korea, Company Share by Revenue ($m), USD Constant, 2025
Table 46: Metabolic Disorders Market Pipeline Products
Table 47: Metabolic Disorders - Pipeline Products by Stage of Development
Table 48: Metabolic Disorders Companies - Pipeline Products by Stage of Development
Table 49: Metabolic Disorders - Pipeline Products by Segment
Table 50: Metabolic Disorders - Pipeline Products by Territory
Table 51: Metabolic Disorders - Pipeline Products by Regulatory Path
Table 52: Metabolic Disorders - Pipeline Products by Estimated Approval Date
Table 53: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

Figure 1: Metabolic Disorders Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Figure 2: Metabolic Disorders Market, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Figure 3: Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
Figure 4: Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
Figure 5: Metabolic Disorders Market, Asia-Pacific, Company Share (%), 2025
Figure 6: Metabolic Disorders Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 7: Cholesterol Tests Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 8: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 9: Metabolic Disorders Market, Australia, Volume (Units), 2024-2036
Figure 10: Cholesterol Tests Market, Australia, Volume (Units), 2024-2036
Figure 11: Diabetes Assays Market, Australia, Volume (Units), 2024-2036
Figure 12: Metabolic Disorders Market, Australia, Company Share (%), 2025
Figure 13: Metabolic Disorders Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 14: Cholesterol Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 15: Diabetes Assays Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 16: Metabolic Disorders Market, China, Volume (Units), 2024-2036
Figure 17: Cholesterol Tests Market, China, Volume (Units), 2024-2036
Figure 18: Diabetes Assays Market, China, Volume (Units), 2024-2036
Figure 19: Metabolic Disorders Market, China, Company Share (%), 2025
Figure 20: Metabolic Disorders Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 21: Cholesterol Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 22: Diabetes Assays Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 23: Metabolic Disorders Market, India, Volume (Units), 2024-2036
Figure 24: Cholesterol Tests Market, India, Volume (Units), 2024-2036
Figure 25: Diabetes Assays Market, India, Volume (Units), 2024-2036
Figure 26: Metabolic Disorders Market, India, Company Share (%), 2025
Figure 27: Metabolic Disorders Market, Japan, Revenue ($m), USD Constant, 2024-2036
Figure 28: Cholesterol Tests Market, Japan, Revenue ($m), USD Constant, 2024-2036
Figure 29: Diabetes Assays Market, Japan, Revenue ($m), USD Constant, 2024-2036
Figure 30: Metabolic Disorders Market, Japan, Volume (Units), 2024-2036
Figure 31: Cholesterol Tests Market, Japan, Volume (Units), 2024-2036
Figure 32: Diabetes Assays Market, Japan, Volume (Units), 2024-2036
Figure 33: Metabolic Disorders Market, Japan, Company Share (%), 2025
Figure 34: Metabolic Disorders Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 35: Cholesterol Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 36: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 37: Metabolic Disorders Market, South Korea, Volume (Units), 2024-2036
Figure 38: Cholesterol Tests Market, South Korea, Volume (Units), 2024-2036
Figure 39: Diabetes Assays Market, South Korea, Volume (Units), 2024-2036
Figure 40: Metabolic Disorders Market, South Korea, Company Share (%), 2025
Figure 41: Metabolic Disorders - Pipeline Products by Stage of Development
Figure 42: Metabolic Disorders - Pipeline Products by Segment
Figure 43: Metabolic Disorders - Pipeline Products by Territory
Figure 44: Metabolic Disorders - Pipeline Products by Regulatory Path
Figure 45: Metabolic Disorders - Pipeline Products by Estimated Approval Date